Pharmaceuticals: Other
Austrian companies producing specialized pharmaceuticals
Firms in this secondary pharmaceutical group focus on niche therapeutics, animal health products, or specialized clinical compounds. Specific patent rulings and localized regulatory approvals inject sudden volatility into these stocks. Right now, Biogena Group Invest AG tops trading volume. You can find more fundamental and technical metrics in the table below.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 ABVXAbivax SA | 6.96 B EUR | 75.65 EUR | −6.83% | 3 | 0.75 | — | −5.23 EUR | −59.53% | 0.00% | Health technology | Strong buy |
 PHMPharma Mar SA | 1.19 B EUR | 66.85 EUR | 0.00% | 0 | — | 17.06 | 3.92 EUR | +102.78% | 1.21% | Health technology | Buy |
 BIOBiogena Group Invest AG | — | 4.86 EUR | −0.41% | 297 | 0.19 | — | — | — | — | Health technology | No rating |